The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Study of a Patient with Breast Cancer Treated with a Combination of Traditional Korean Medicine and Chemotherapy

유방암에 대한 한양방 병용 치료 증례 보고 1례

  • Received : 2017.09.11
  • Accepted : 2017.10.27
  • Published : 2017.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

The prevalence of breast cancer is very high in Korea. Although the patients receive standard treatments, such as surgery, chemotherapy, or radiotherapy, they frequently experience recurrence or metastasis of their tumors. In addition, many patients with breast cancer also suffer from side effect symptoms induced by these standard treatments. Therefore, increasing numbers of patients now want to undergo treatment with traditional Korean medicine (TKM) in addition to conventional treatment. We present a case of 46-year-old female with recurred breast cancer. She first received two kinds of chemotherapy and then underwent surgery. She then also received 4 cycles of adjuvant chemotherapy. At a follow-up examination, she was informed of recurrent lesions on the right anterior chest wall. She started to receive TKM treatments together with a new chemotherapy. After about one month, the size of the recurred tumor in right chest wall had decreased. Her symptoms, such as shoulder pain, chest pain, and nausea induced by conventional therapy, were also improved. We suggest that a combination of TKM and chemotherapy is a promising treatment for breast cancer.

Keywords

References

  1. Lee NH, Lee KW, Yoo HS, Lee JS. A Preliminary Study for Development of Clinical Practice Guidelines of Korean Medicine in Breast Cancer. J Korean Obstet Gynecol 2016:29(2):47-65. https://doi.org/10.15204/JKOBGY.2016.29.2.047
  2. Chen Z. Furenliangfangdaiquan. Seoul: Jungdam; 1993, p. 71.
  3. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J clin 2014;64(1):9-29. https://doi.org/10.3322/caac.21208
  4. Desantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics 2013. CA Cancer J clin 2014;64(1):52-62. https://doi.org/10.3322/caac.21203
  5. Park B, Choi KS, Lee YY, Jun JK, Seo HG. Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey. Asian Pac J Cancer Prev 2012;13(4):1187-91. https://doi.org/10.7314/APJCP.2012.13.4.1187
  6. den Hollander P, Savage MI, Brown PH. Targeted Therapy for Breast Cancer Prevention. Front Oncol 2013;3(250):1-15.
  7. Woo HD, Kim HS, Lee JH, Kim HM, Han SW, Kim SY, et al. Toxicity and Tolerability Study of Adjuvant TAC Regimen Chemotherapy in Korean Patients with Breast Cancer. J Breast Cancer 2011;14(S):S44-9. https://doi.org/10.4048/jbc.2011.14.S.S44
  8. Seo JY, Yi M. Distress and Quality of Life in Cancer Patients Receiving Chemotherapy. Asian Oncol Nurs 2015;15(1):18-27. https://doi.org/10.5388/aon.2015.15.1.18
  9. Kim JH, Bae KR, Park SJ, Cho CK, Yoo HS. A Case of Patient with Recurring Non-Small Cell Lung Carcinoma Treated with Samchilchoongcho-Jung in Conjunction with Afatinib. J Int Korean Med 2017;38(1):72-80.
  10. Jang AY, Song EJ, Shin SH, Hwang PH, Kim SY, Jin YW, et al. Potentiation of natural killer(NK) cell activity by methanol extract of cultured cambial meristematic cells of wild ginseng and its mechanism. Life Sci 2015;135:138-46. https://doi.org/10.1016/j.lfs.2015.06.018
  11. Wang W, Zhang X, Qin JJ, Voruganti S, Nag SA, Wang MH, et al. Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2. PLoS One 2012;7(7):e41586. https://doi.org/10.1371/journal.pone.0041586
  12. Choi WC. Study on the Safety and Antitumor Activity of Rhus Verniciflua Extract(Nexia). Graduate School of East-West Medicine. Kyunghee University 2006.
  13. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R. New response evaluation criteria in solid tumours: Revised RECIST guideline(version 1.1). Eur J Cancer 2009;45(2):228-47. https://doi.org/10.1016/j.ejca.2008.10.026
  14. National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE) v.4.0, 2010. Available at http://evs.nci.nih.gov/ftp1/CTCAE/About.html)
  15. Jang HJ. Molecular mechanism by which Resina Toxicodendrii induces apoptosis and suppresses chemoresistance in MCF-7/DOX cells. Graduate School of Korean Medicine. Kyunghee University 2017.
  16. Song MS, Kim YS, Leem EM. The literature review for Resina Toxicodendrii. J Korean Obstet Gynecol 2002;15(1):60-76.
  17. Lee SH, Cho JK. The literature review for inhibition of tumor metastasis and growth using ‘activate blood and resolve stasis' method. Journal of Korean Oriental Medical Research Institute, Daejeon University 1998;7(1):700.
  18. Kaufman SH. Apoptosis: Pharmacological Implication and Therapeutic Opportunities. San Diego, California: Academic Press; 1997.
  19. Bernard MM, McConnery JR, Hoskin DW. [10]-Gingerol, a major phenolic constituent of ginger root, induces cell cycle arrest and apoptosis in triple-negative breast cancer cells. Exp Mol Pathol 2017;102(2):370-6. https://doi.org/10.1016/j.yexmp.2017.03.006
  20. Jiang K, Lu Q, Li Q, Ji Y, Chen W, Xue X. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling. Int Immunopharmacol 2017;42:195-202. https://doi.org/10.1016/j.intimp.2016.10.001
  21. Bang SH, Kwon KR, Yoo HS. Two cases of Non-Small Lung Cancer Treated with Intravenous Cultivated Wild ginseng Pharmacopuncture. Journal of Phramacopuncture 2008;11(2):13-9.
  22. Cho BJ, Kwon KR. Proposal of Self Targeting Therapy of Mountain Ginseng Pharmacopuncture. Journal of Phramacopuncture 2011;14(2):75-80. https://doi.org/10.3831/KPI.2011.14.2.075
  23. Lee KK, Kim JY, Jung JH, Park JY, Park HY. Clinicopathological Feature and Recurrence Pattern of Triple Negative Breast Cancer. J Korean Surg Soc 2010;79(1):14-9. https://doi.org/10.4174/jkss.2010.79.1.14
  24. Han SA, Jang BH, Hwang DS, Suh HS. Experiences of Treatment-Related Side Effects and Supportive Care with Korean Medicine in Women with Breast Cancer - A Focus Group Study. J Korean Obstet Gynecol 2017;30(1):85-94. https://doi.org/10.15204/jkobgy.2017.30.1.085
  25. Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014;50:346-58.

Cited by

  1. 유방암에 대한 국내 한의학 연구 동향 고찰 - 국내 한의학 논문을 중심으로 - vol.39, pp.1, 2017, https://doi.org/10.22246/jikm.2018.39.1.44
  2. 유방암 환자의 cyclophosphamide, doxorubicin 유발 부작용에 대한 약침을 포함한 통합 암 치료 1례 vol.23, pp.1, 2017, https://doi.org/10.15432/jkto.2018.23.1.033
  3. 악성 난소 생식세포 종양 환자의 항암 치료 후 발생한 부작용 증상에 대한 한방치료 증례 보고 1례 vol.32, pp.4, 2017, https://doi.org/10.15204/jkobgy.2019.32.4.144
  4. 호르몬 수용체 및 HER-2 수용체 양성 유방암 4기 다발성 전이 환자의 6년간의 한양방 병용치료 치험 1례 vol.24, pp.2, 2017, https://doi.org/10.15432/jkto.2019.24.2.013
  5. 항암화학요법과 통합의학치료를 병행하여 부분 관해 된 간전이 동반 말기 췌장암 1례 vol.41, pp.2, 2017, https://doi.org/10.22246/jikm.2020.41.2.166
  6. 유방암 환자의 항암화학요법 후 한방병원 입원치료에 대한 일개 한방병원 환자 특성 및 치료 고찰 vol.33, pp.2, 2017, https://doi.org/10.15204/jkobgy.2020.33.2.077